The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open label phase 1b/2 trial of TRC105 and sorafenib in patient with advanced/metastatic hepatocellular carcinoma (HCC) (NCT01806064).
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - Bayer; Genentech (Inst)
 
Kabir Mody
Consulting or Advisory Role - Celgene; Genentech/Roche; Merrimack
Research Funding - ARIAD; FibroGen; MedImmune; Senhwa Biosciences; TRACON Pharma
 
Tim F. Greten
No Relationships to Disclose
 
Ravi Kumar Paluri
No Relationships to Disclose
 
Richard T. Lee
No Relationships to Disclose
 
Brian E Simpson
Employment - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
 
Bonne J. Adams
Employment - TRACON Pharma
Leadership - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
 
Charles P. Theuer
Employment - TRACON Pharma
Leadership - 4D Molecular Therapeutics; TRACON Pharma
Stock and Other Ownership Interests - 4D Molecular Therapeutics; TRACON Pharma
 
Ahmed Omar Kaseb
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Bayer Health; Bristol-Myers Squibb
Consulting or Advisory Role - Bayer Health; Bristol-Myers Squibb
Research Funding - Bayer Health; Bristol-Myers Squibb; Merck; TRACON Pharma
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; TRACON Pharma